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Reovirus m2 protein was constitutively expressed in mammalian cells transfected with dicistronic constructs in which
the reovirus M1 gene and the selectable neomycin-resistant gene (neo) were both driven by the same phosphoglycerate
kinase promoter. Translation of neo was initiated with the cap-independent translation initiation element from encephalomyo-
carditis virus. Expression of m2 protein was detected by m2-specific antibody produced through immunization of rabbits
with Trp-E-m2 fusion proteins expressed in Escherichia coli. The expression levels of m2 proteins of serotype 1 (T1) and
serotype 3 (T3) were different and varied in different mouse cell lines with T1 being expressed more efficiently than T3.
m2-expressing L929 cell lines generated with the dicistronic constructs were highly stable. Inclusion of the transforming
fragment of bovine papillomavirus in the dicistronic construct lead to higher levels of m2 expression that were less stable
and thus decreased on continued cell culture. The m2 protein expressed in transfectants was authentic as shown by peptide
mapping comparison with m2 protein from reovirus-infected cells and that from in vitro transcription and translation of the
M1 gene. It was further shown that the m2 protein expressed in a stable L929 cell line complemented the growth of the
reovirus tsH11.2 mutant with a defect in its M1 gene. It is concluded that the m2 protein stably expressed by transfection
is functionally equivalent to m2 protein expressed by reovirus. q 1996 Academic Press, Inc.
Mammalian reovirus is the prototype of orthoreovirus, al., 1993), myocarditis in the mouse (Sherry and Fields,
1989; Sherry and Blum, 1994), as well as virulence in theone of the six genera of the family Reoviridae. Reovirus
has 10 double-stranded RNA (dsRNA) genome seg- liver of infected animals (Haller et al., 1995).
Characterization of reovirus M1 deletion mutants hasments, each encoding a single protein with the exception
of S1 which is functionally dicistronic and encodes two identified the consensus termini of M1 required for repli-
cation and encapsidation, consisting of 132–135 nucleo-proteins in separate reading frames (reviewed by Schiff
and Fields, 1990). One of the three medium-size genome tides (nt) from the 5* end and 183–185 nt from the 3*
end of the M1 plus strand (Zou and Brown 1992b). Thissegments, M1, encodes m2 protein which is a minor com-
ponent of the viral core, present in about 12 copies per information will be applicable to production of a packag-
ing and selection system for the introduction of an M1viral particle (Schiff and Fields, 1990). The M1 genome
segments of both serotype 3 (T3) and serotype 1 (T1) are analogue containing the identified consensus se-
quences into reovirus. However, reovirus possessing an2304 nucleotides long, containing a single large open
reading frame from nucleotide 14 to 2224 encoding 736 M1 analogue in place of the wild-type M1 will be replica-
tion defective. The approach taken in this paper to com-predicted amino acids (Wiener et al., 1989; Zou and
Brown, 1992a). Its messenger RNA is translated very inef- plement defective M1 genes was to develop stable cell
lines expressing the M1 gene product, m2 protein.ficiently in infected cells (Gaillard and Joklik, 1985) but
not in vitro (Roner et al., 1989). Viral proteins expressed from transfected DNA constructs
are capable of complementing mutations in the homologousThe analysis of this protein has been lacking presum-
gene of other defective viruses. Expression of the fusionably because of its low abundance in virus particles, poor
protein gene of a virulent Newcastle disease virus strainreactivity with anti-reovirus antibody, and the difficulty of
provides an active fusion protein and complements thedetecting m2 protein by SDS–PAGE since it comigrates
spread of infection by an avirulent Newcastle disease viruswith the abundant m1c protein. Genetic studies using
(Morrison et al., 1991). Stable expression of the vacciniareassortants have associated m2 with the extent of cyto-
virus K1L gene in rabbit cells complements the host rangepathic effect and plaque size in L929 cells (Moody and
defect of a vaccinia virus mutant (Sutter et al., 1994).Joklik, 1989), replication in heart cells in vitro (Matoba et
al., 1991) and bovine aortic endothelial cells (Matoba et Trp-E-m2 FUSION PROTEIN-INDUCED ANTIBODY
WAS m2-SPECIFIC
In this study, m2-specific antibody was first produced1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (613) 562-5452. E-mail: brown@labsun1.med.uottawa.ca. through immunization of rabbits with m2 fusion proteins
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expressed in Escherichia coli, for the detection of m2
expression. T1 M1 and T3 M1 cDNA were subcloned
into the pATH vector with the M1 gene fused in frame
with the E. coli Trp E gene according to the manufactur-
er’s instructions (Oncogene Science, Inc.). Trp-E-m2 fu-
sion proteins of both T1 and T3 were then purified by
SDS–PAGE, excised from the gels, electrophoretically
eluted, and then dialyzed against double-distilled water
(Bell et al., 1984). About 100 mg of the dialyzed fusion
protein was mixed with an equal volume of complete
Freund’s adjuvant to form an emulsion and injected into
a rabbit’s leg muscle. The rabbits were boosted once
after 3 weeks with the same fusion protein mixed with
incomplete Freund’s adjuvant and then bled every week
to test the antibody activity by radioimmunoprecipitation
(RIPA) of reovirus-infected cell lysate using protein A–
sepharose as described by Bell et al. (1984). RIPA of
weekly bleeds showed that in the T1 m2-immunized rab-
FIG. 1. RIPA of m2 proteins from infected cells, in vitro translationbit even the first bleed possessed antibody activity but
products of M1 cDNA transcripts, and melted reovirion dsRNA. The leftin the T3 m2-immunized rabbit the antibody activity devel-
side shows differential precipitations of T1-infected L929 lysate first by
oped more gradually (data not shown). There was only anti-T1 virus antiserum and then by anti-T1m2 and vice versa. Prebleed,
one protein band of the expected size precipitated by indicates T1-infected cells precipitated by prebleed from Trp-E-m2-im-
munized rabbit; mock, indicates L929 cells precipitated with anti-Trp-the antibody. Antiserum produced against T1 and T3 m2
E-T1m2 protein. The other lanes show unprecipitated and precipitatedprotein cross-reacted strongly with each alternate type
in vitro translation products of in vitro T7 transcripts of cloned M1 cDNAof m2 protein (data not shown), which was not surprising
or melted viral dsRNA. Two translation reactions of T1M1 ssRNA were
since the m2 proteins of T1 and T3 have 98.6% amino included in the gel; the lane to the left is of RNA that was heated to
acid homology (Zou and Brown, 1992a). As a result, the 707 for 5 min before translation.
antiserum induced with T1m2 fusion protein was used
throughout this study. The antibody was then tested fur-
other smaller bands that represented presumably shortther for precipitation of m2 proteins from in vitro transla-
translation products from the same reading frame as thetion products of M1 cDNA transcripts and melted dsRNA
full-size m2 protein due to internal initiation or prematureof reoviruses that were translated using rabbit reticulo-
termination. These results indicated that the antibodycyte lysate (Promega Corporation) (Fig. 1). The first five
induced in rabbits by fusion m2 proteins expressed in E.lanes show the proteins in T1-infected L cell lysates that
coli reacted specifically with reovirus m2 proteins.were sequentially immunoprecipitated with anti-T1 reovi-
rus serum and anti-m2 fusion protein in both possible
orders of reaction. The amount of m2 protein is similar CONSTITUTIVE EXPRESSION OF m2 PROTEIN
whether it follows or precedes subsequent immunopre-
cipitation of the same lysate with anti-T1 immune serum M1-containing monocistronic or dicistronic DNA con-
structs were then generated for the expression of m2as predicted by its lack of immune response to m2 pro-
tein. The s proteins in the lane ‘‘2nd precip anti-m2’’ were proteins in transfected cells. T1 M1 and T3 M1 gene
DNA sequences cloned in pGEM were subcloned intolikely due to residual protein A beads from the first immu-
noprecipitation with the anti-virus antibody as the precipi- the mammalian expression vector pKJ1 (a gift from Dr.
M. McBurney, University of Ottawa) under the control oftation with the anti-m2 antibody first (lane ‘‘anti-m2’’) did
not have these protein bands. It can also be seen from the mouse phosphoplycerate kinase (pgk) promoter
(Boer et al., 1990; McBurney et al., 1991). The pgk pro-this sequential precipitation that the concentration of m2
protein in infected cells was relatively high when com- moter used in this study drives the normal housekeeping
gene, phosphoglycerate kinase, and thus was a promis-pared with the abundant proteins m1c and s3. Protein of
the mobility of m2 protein was not precipitated from nor- ing promoter for constitutive expression. Pgk-driven neo
constructs were shown to give rise to more than 10 timesmal L929 cell lysate by anti-Trp-E-m2 antibody or from
reovirus-infected L929 by preimmunization serum (Fig. as many drug-resistant colonies as pSV2neo that has an
SV40 promoter (McBurney et al., 1991). The neomycin-1). The m2 antibody could precipitate one dominant pro-
tein band from in vitro translations of both M1 cDNA resistant gene from transposon Tn5 (Beck et al., 1982)
was chosen as the selectable marker for the selection oftranscripts and melted reovirion dsRNA which aligned
with the protein precipitated from reovirus-infected cells transfectants. For generation of monocistronic constructs
(pKJ1M1neo), neo plus the SV40 promoter and the poly(A)on SDS–PAGE. RIPA of in vitro translation products gave
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were then separated by SDS–PAGE (Laemmli, 1970) and
detected by autoradiography.
Transfection of mouse fibroblast L929 cells with the
T1 and T3 m2 monocistronic constructs pKJ1M1neo fol-
lowed by G418 selection gave a low but detectable level
of T1m2 and possibly T3m2 expression in the uncloned
pools of G418-resistant transfectants, which was not de-
tectable in transfections with constructs containing theFIG. 2. Structure of the M1 gene-containing cDNA constructs used
reverse orientation of the M1 gene (data not shown).for transfection. The monocistronic pKJ1M1neo contains M1 driven by
the pgk promoter and neo driven by the SV40 promoter. The dicistronic However, screening of 18 clones of cells transfected by
M1CN has M1 and neo under the same pgk promoter with the internal T1 M1 and 15 clones of cells transfected by T3 M1 in a
ribosome entry site from EMCV, the CITE element, between M1 and repeat transfection did not give any clones that ex-
neo. M1CN-BPV is M1CN plus the 69% transforming fragment of BPV.
pressed a detectable level of m2 protein, indicating that
expression was poor from this type of construct.
It was reasoned that if both M1 and neo were put intosignal was first cut out of plasmid pMAMneo (Clontech
one construct under one promoter with M1 upstream ofLaboratories, Inc.) and inserted into pKJ1 downstream of
neo, selection with G418 would select for higher levels ofthe pgk polyadenylation signal. The dicistronic con-
m2 expression. Transfection of L929 with the dicistronicstructs (M1CN) were generated by insertion of neo into
constructs (two clones for each of T1 and T3) of M1CNpKJ1 followed by insertion of M1 upstream of neo. The
did give higher m2 expression, with T1 m2 much higherneo gene was obtained from plasmid pMAMneo by poly-
than T3 m2 (Fig. 3). Furthermore, four of four clones ofmerase chain reaction. The neo gene was translated due
cells from transfection by T1 M1 were positive for m2to the addition of a cap-independent translation initiation
expression. The highest level of m2 expression was seenelement (CITE) from encephalomyocarditis virus (EMCV).
for clone T1-11-1 that was 5% of the level seen inCITE was cut out of plasmid pCITE-1 (Novagene) with
infected cells as determined by densitomitry of the auto-EcoRI and NcoI and inserted between M1 and neo such
radiogram. The half-life of T1 m2 protein produced in T1-that neo was fused with the two in-frame AUGs in CITE
11-1 cells was similar to that of m2 protein synthesizedthat were nine nucleotides apart. Further modification
in T1 infection (approximately 6 hr) (data not shown),was the inclusion of the bovine papillomavirus (BPV)
indicating that the low level of m2 expression resultingtransforming fragment (69% portion) derived from plas-
from transfection was not due to instability.mid p306 (a gift of Dr. J. Campione, Health Canada) by
The m2 protein expression level was stable in the m2-HindIII and BamHI digestion and inserted into the HindIII
expressing cell lines since the m2 expression level re-site following the pgk poly(A) signal of M1CN constructs
mained unchanged after passage of the cells for over 6(M1CN–BPV). Inclusion of the transforming fragment of
months or after liquid nitrogen storage of the cells (dataBPV into expression vectors has been reported to in-
not shown). Passage of clone T1-11-1 for over 2 yearscrease expression efficiency as the BPV fragment allows
(in the absence of G418) maintained the same level ofepisomal replication of the transfecting plasmid and thus
expression (data not shown).provides amplification of the gene to be expressed by a
gene dosage effect (reviewed by DiMaio, 1987). The
three types of constructs are shown in Fig. 2.
Mouse cell lines L929, NIH/3T3, and C127I were
transfected with specific DNA constructs by cationic lipid
transfection using the reagent lipofectin and protocol
from GIBCO-BRL. Since the selectable marker in tranfect-
ing plasmid DNA constructs was the neomycin-resistant
gene, Geneticin (G-418) (500 mg/ml) was used for the
selection of stable transfectants. The medium was
changed every 7 days. After most of the host cells died,
FIG. 3. m2 expression in L929 cells transfected with the dicistronic1
3 volume of conditioned medium was included in the constructs M1CN. Following transfection and selection resistant colo-
overlay. Generally, colonies of resistant cells were visible nies of cells were grown up and tested by RIPA with m2 antibody. T1,
by 2 weeks under selection. Individual colonies were lysates of T1-infected L929; mock, mock-infected L929; M1-neo fusion,
precipitation by m2 antibody of the pool of resistant colonies frompicked, transferred to fresh flasks, and grown up for test-
transfection of L929 cells by a construct in which neo was fused toing m2 expression. At this stage, the selection pressure
the T1M1 5*-terminal 135 nucleotides and the M1-neo was driven by
was lifted but conditioned medium was still included. the pgk promoter. T1-9/T1-11 were clones of M1CN T1M1 constructs
RIPA was used to detect proteins expressed in infected and T3-1/T3-6 were clones of M1CN T3M1 constructs. The pool of
transfectants from T3-6 was lost during passage.or transfected cells. The immunoprecipitated proteins
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tion by RIPA, the expression in L929 cells was not im-
proved (data not shown). It has been shown that in 3T3
or C127 cells, BPV-containing constructs tend to exist as
plasmids with multiple copies whereas in some other
cells they tend to become integrated and consequently
give low expression as was seen for our BPV constructs
in L929 cells (DiMaio et al., 1982; Sambrook et al., 1985).
Transfection of 3T3 cells gave much higher expression
of T3 m2 than that from M1CN constructs in L929 cells.
Transfections of C127I cells yielded higher T1 m2 expres-
sion, compared to T1-11-1, the L929 cell line expressing
the highest level of T1m2 with construct M1CN (Fig. 5).
The level of T3m2 expression was considerably lower
than that of T1m2 in C127I cells (Fig. 5), whereas expres-
sion was similar in 3T3 cells (data not shown) with the
exception of one clone of 3T3 transfected by T3M1-con-
taining M1CN–BPV (T3-15-33 clone 1, lane ‘‘3T3/T3m2’’
FIG. 4. m2 protein constitutively expressed in L cells was indistin-
in Fig. 5) that was among the highest levels attained (Fig.guishable by peptide mapping from authentic m2 protein. m2 protein
5). This data showed that it was possible to get higherwas precipitated with anti-m2 antibody from T1 virus-infected L929 and
the m2-expressing L929 clone T1-11-1. m1c was precipitated with anti- expression of m2 and that different types of mouse cells
T1 virus antibody from T1-infected L929. These proteins and the in vitro had different abilities to express m2 protein. However,
translation product of the T7 transcript of M1 cDNA cloned in pGEM the level of m2 expression from the BPV-containing con-
were purified by SDS–PAGE, detected by autoradiography, excised,
structs was less stable and decreased to lower but de-and loaded onto 15% gels of SDS–PAGE. V8 protease of the indicated
tectable levels after continuous passage of the cell linesamount was then added to each sample well and electrophoresis was
carried out as described by Cleveland et al. (1977). (data not shown). Presumably the BPV-containing plas-
mid decreased in copy number or rearranged during se-
rial passage as documented for this type of vector (Di-
THE m2 PROTEIN FROM TRANSFECTED CELLS
Maio, 1987; Kitamura et al., 1991).
WAS INDISTINGUISHABLE FROM VIRAL m2 BY
PEPTIDE MAPPING
THE m2-EXPRESSING CELL LINE T1-11-1
To test if the m2 protein expressed in transfected cells COMPLEMENTED THE GROWTH OF THE
was identical with that produced during reovirus infec- M1 ts MUTANT tsH11.2
tion, m2 proteins were subjected to peptide mapping us-
One of the goals of expressing m2 stably in mammalianing partial proteolysis and SDS–PAGE. Proteins were
cells was to complement the defective function of m2purified by RIPA with m2 antibody from T1 Lang-infected
protein for reoviruses containing a foreign gene in placecells, from in vitro translation of T1 M1 cDNA transcripts,
of authentic M1. To assess the ability of m2 expressionas well as from the T1 m2-expressing cell line T1-11-1
to complement a ts defect, the m2-expressing L929 cloneand then digested with Staphylococcus aureus V8 prote-
T1-11-1 was infected with the M1 ts mutant tsH11.2 thatase as described by Cleveland et al. (1977). The m1c
is restricted in replication at temperatures higher thanprotein which runs very close to m2 on SDS–PAGE was
397 (gift of K. Coombs). tsH11.2 is restricted in growth atalso precipitated with anti-reovirus antibody from T1
Lang-infected cells and digested with V8 protease. The
digestion patterns of m2 proteins from different sources
were indistinguishable from each other but were clearly
different from that of m1c, indicating that the m2 protein
stably expressed by transfection was the same as the
authentic m2 protein (Fig. 4).
Although the reovirus M1 gene was constitutively ex-
pressed in L929 the level of m2 expressed was relatively
low especially for T3 m2 protein. To increase the level of
FIG. 5. m2 expression in NIH/3T3 and C127I transfected with M1CN-expression, the transforming fragment of bovine papillo-
BPV. Cloned cells of transfectants were labeled, lysed, precipitated bymavirus was introduced into the M1CN constructs and
anti-m2 antibody, and analyzed by 7.5% SDS–PAGE. Only the 3T3 clonethe new constructs, termed M1CN–BPV, were
expressing the highest level of T3m2 on transfection with the M1CN-
transfected into L929, NIH/3T3, and C127I cells. After BPV construct (T3-15-33 clone 1) and the L929 clone expressing the
selection with G418 and screening of the pool and 4 to highest level of T1m2 on transfection with the M1CN construct (T1-11-
1) are shown in this figure.15 clones of resistant transfectants from each transfec-
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at 39.57 the growth of wt T1 was not adversely affected
but the growth of tsC447 and tsG453 was inhibited in all
cell types yielding titers that were about 10,000 times
lower than those at 337. However, the yield of tsH11.2 in
the m2-expressing T1-11-1 cells at 39.57 was comple-
mented, such that the titer was similar to the yield at 337
(2.9 1 107 versus 5 1 107 PFU/ml), compared to the
dramatic decrease in virus yield at 39.57 relative to 337
in normal L929 cells (9 1 104 versus 2.8 1 107 PFU/ml)
or in the control transfectant pKJ2 cells (3.7 1 104 versus
1.7 1 107 PFU/ml), indicating that the complementation
in T1-11-1 cells was not due to properties of the plasmid
vector background. The results clearly demonstrated that
(1) the m2-expressing cell line T1-11-1 complemented the
growth of the M1 ts mutant tsH11.2 and (2) the comple-
mentation was specific for the M1 gene defect as neither
of the other two reovirus ts mutants could be comple-
mented by the m2-expressing cell line.
FIG. 6. Plaque formation of the M1 ts mutant tsH11.2 at permissive To confirm that the complementation was phenotypic
and nonpermissive temperatures on normal L929 and the m2-express-
and not the result of genetic reversions or acquisition ofing T1-11-1 cells. The data were the result of triplicate assays at 39.57
the M1 gene expressed in T1-11-1 cells the virus har-and duplicate assays at 337.
vests of tsH11.2 from T1-11-1 cells at 39.57 were also
titrated at 39.57. The titers for tsH11.2 at 39.57 versus
337 were 4.5 1 104 and 2.9 1 107 PFU/ml, respectively,39.57 due to mutations in the M1 gene (K. Coombs, per-
sonal communication). The ts mutant was first plaqued indicating that the complementation was indeed pheno-
typic since the efficiency of plating of tsH11.2 was similarin normal L929 cells and the m2-expressing T1-11-1 cells
at the permissive temperature 337 and at the nonpermis- whether grown on wild-type L929 cells (1.5 1 1003) or
m2-expressing, T1-11-1, cells (1.4 1 1003).sive temperature 39.57. Triplicate and duplicate plaque
assays were performed at 39.5 and 337, respectively. The Further time course studies showed that in m2-ex-
pressing L929 cells (T1-11-1) the ts mutant grew fasterplaque-forming efficiency of tsH11.2 on m2-expressing
cells was over 200 times higher than that from normal and reached peak titers 6–12 hr earlier than in normal
L929 at 39.57 (Fig. 8). Furthermore, in normal L929 atL929 at 39.57 (6.2 1 107 PFU/ml versus 2.8 1 105 PFU/
ml), whereas at 337 the plaque-forming efficiency on nor- nonpermissive temperature the virus titer decreased
after reaching its peak at 24 hr postinfection, suggestingmal L929 was slightly higher than that from m2-express-
ing cells T1-11-1 (2.01 108 PFU/ml versus 3.31 107 PFU/ that ts viruses produced in wild-type L929 cells at non-
permissive temperature were not as stable as those pro-ml) (Fig. 6), indicating that the m2 protein constitutively
expressed in L929 cells was able to complement the duced in m2-expressing L929 cells (Fig. 8).
The complementation of tsH11.2 indicates that the m2replication of the M1 ts mutant tsH11.2, as shown by
the increased ability to form plaques at nonpermissive protein expressed from transfected M1 DNA constructs
is functional and that the expression level reached in T1-temperature.
To test if the complementation is specific to the M1 11-1 is sufficient to support reovirus replication. There-
fore, these L929 cell lines that constitutively and stablygene defect, normal L929 cells, m2-expressing T1-11-1
cells, and L929 cells transfected by pKJ2, a plasmid that express m2 protein may provide a way to cultivate engi-
neered, foreign gene-containing reoviruses. Initial at-contains the neo gene driven by the pgk promoter (a gift
of M. McBurney), were infected at an m.o.i. of 3 by wild- tempts to isolate M1 deletion mutants on m2-expressing
T1-11-1 cells have been unsuccessful. It is possible thattype reovirus type 1 (wt T1) and three ts mutants, tsH11.2,
tsC447, and tsG453, that have ts mutations mapped to some function(s) of m2 protein require higher levels of
m2 protein to be complemented.segment M1, S2, and S4, respectively. Following incuba-
tion at 33 or 39.57 for 72 hr viruses were harvested and As for the mechanism of complementation, presum-
ably the wild-type m2 protein expressed in the transfec-titrated in normal L929 cells at 337. Triplicate infections
by tsH11.2 or tsC447 and duplicate infections by wt T1 tants supplied the missing function of the mutant tsH11.2.
Given that about 12 copies of m2 protein are present inor tsG453 were performed for each cell type and at each
temperature condition. The virus yields were assayed at the interior of the virion core it is assumed that this virion-
associated protein supplies at least one critical, probablypermissive temperature on L929 cells (Fig. 7). At 337 the
growth of each virus in the three types of cells showed enzymatic function. If this function preceded transcription
then complementation of that defect would not be possi-no significant difference (Fig. 7A). In all three cell types
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FIG. 7. Complementation of the M1 ts mutant tsH11.2 by m2 protein expressed in T1-11-1 L929. (A) Yield of virus at 337. (B) Yield of virus at 39.57.
Normal L929, the m2-expressing L929 cell line (T1-11-1), and L929 cells transfected by the vector control (pKJ2) were infected separately with wild-
type reovirus T1 (wt T1), tsH11.2, tsC447, and tsG453 at an m.o.i. of 3. Duplicate infections were performed for wt T1 and tsG453 and triplicate
infections for tsH11.2 and tsC447. Following incubation at 33 or 39.57 for 72 hr viruses were harvested by freeze–thaw three times and titrated at
337 in normal L929 cells. In panel B, the titers of virus yield from infection of T1-11-1 by tsG453 and tsC447 were less than 104 PFU/ml.
ble unless the virion was functionally wild type but genet- mentation. As the m2 protein from tsH11.2 could not be
differentiated from the wild-type m2 either by electropho-ically mutant as is tsH11.2 grown at permissive tempera-
ture. The m2 protein is present at relatively high concen- resis or by antibody detection (data not shown), we could
not show if the wild-type m2 was incorporated into thetration in infected cells (vide infra), relative to other
abundant proteins m1c and s3, and may serve other func- virion or just functioned in trans. The reduced stability of
tsH11.2 produced at nonpermissive temperature in wild-tions before or concomitant with virion assembly where
the m2 protein is sequestered in the core of the virion. type L929 relative to m2-expressing T1-11-1 cells sug-
gested that viruses incorporated the wild-type m2 proteinWithout knowing the functional and structural roles of m2
protein we cannot predict the mechanism for comple- from the host cells in order to be more stable. Further
work on the nature of complementation by m2 expression
may shed light on the role it plays in a specific stages(s)
in reovirus infection.
The m2-expressing cell lines can also be used to study
the function of m2 and the interactions of m2 with host
cells. T1 and T3 m2 expression levels differed signifi-
cantly in the same type of cells and varied among differ-
ent cell types. In L929 cells transfected with the monocis-
tronic constructs pKJ1M1neo or the dicistronic constructs
M1CN, expression of T1 m2 protein was always signifi-
cantly higher than that of T3 m2 protein, which was true
for both transient and stable expression. With constructs
M1CN–BPV, expression of T1 m2 was much higher than
that of T3 m2 in C127I cells but was comparable in 3T3
cells. These data suggest interactions either between
host factors and the M1 mRNA or between host factors
and the m2 protein. In infected L929 cells, the yield of T1
virus is always higher than that of T3 virus. Possibly the
interactions of M1 mRNA or m2 protein with the host
contribute to this difference. Previous data on the biologi-
FIG. 8. Growth kinetics of tsH11.2 in normal L929 and the m2-express- cal and genetic effects of m2 protein are also consistent
ing L929. Thirty-five-millimeter dishes of L929 and of T1-11-1 were with interaction with host factors such as plaque size,
infected by tsH11.2 at an m.o.i. of 15 and incubated at 33 or 39.57. CPE, growth of reovirus in cardiac cells and bovine aortic
Dishes were frozen at various times before harvesting by freeze–thaw
endothelial cells, pathogenesis, and virulence in liver(31) and titration by plaque assay. Growth of tsH11.2 (j) on normal
cells of infected animals (Moody and Joklik, 1989; MatobaL929 at 39.57 and (.) on T1-11-1 at 39.57; growth of wt T1 Lang virus
(l) on normal L929 at 337 and (m) on T1-11-1 at 337. et al., 1991, 1993; Sherry and Fields, 1989; Sherry and
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combined immunodeficient mice: Organ-specific virulence genes. J.Blum, 1994; Haller et al., 1995). Apparently, either the 51
Virol. 69, 357–364.nucleotide substitutions and/or the 10 amino acid differ-
Kitamura, Y., Naito, A., and Yoshikura, H. (1991). Illegitimate recombina-
ences between T1 and T3 (Zou and Brown, 1992a) are tion in a bovine papillomavirus shuttle vector: A high level of site
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